Organigram Holdings Sees Robust Growth in Q3
Company Announcements

Organigram Holdings Sees Robust Growth in Q3

Story Highlights

OrganiGram Holdings (TSE:OGI) has released an update.

Organigram Holdings reports a significant increase in third-quarter fiscal 2024 net revenue, up 25% to $41.1 million, along with a positive adjusted EBITDA of $3.5 million, marking substantial growth over the previous year. The company also establishes a European presence through a strategic investment in Germany’s Sanity Group, enhancing its global market reach.

For further insights into TSE:OGI stock, check out TipRanks’ Stock Analysis page.

Related Articles
TheFlyBiotech Alert: Searches spiking for these stocks today
TheFlyBiotech Alert: Searches spiking for these stocks today
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Optimize your mobile reading experience. Download the TipRanks App today!